Why GlycoMimetics Inc (NASDAQ: GLYC) Stock Shouldn’t Be Sold In 2024

In the last trading session, 2.22 million GlycoMimetics Inc (NASDAQ:GLYC) shares changed hands as the company’s beta touched 1.82. With the company’s per share price at $0.42 changed hands at $0.01 or 1.26% during last session, the market valuation stood at $26.43M. GLYC’s last price was a discount, traded about -740.48% off its 52-week high of $3.53. The share price had its 52-week low at $0.14, which suggests the last value was 66.67% up since then. When we look at GlycoMimetics Inc’s average trading volume, we note the 10-day average is 120.0 million shares, with the 3-month average coming to 19.25 million.

Analysts gave the GlycoMimetics Inc (GLYC) stock a consensus recommendation rating of Hold, calculated at a mean rating of 3.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended GLYC as a Hold, 0 felt it is a Buy and 0 rated the stock as Underweight. GlycoMimetics Inc’s EPS for the current quarter is expected to be -0.11.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

GlycoMimetics Inc (NASDAQ:GLYC) trade information

Instantly GLYC was in green as seen at the end of in last trading. With action 1.85%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -82.31%, with the 5-day performance at 1.85% in the green. However, in the 30-day time frame, GlycoMimetics Inc (NASDAQ:GLYC) is 178.21% up. Looking at the short shares, we see there were 1.83 million shares sold at short interest cover period of 3.32 days.

GlycoMimetics Inc (NASDAQ:GLYC)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 3.12% of GlycoMimetics Inc shares while 53.43% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 55.16%. There are 53.43% institutions holding the GlycoMimetics Inc stock share, with BVF INC/IL the top institutional holder. As of 2024-06-30, the company held 14.8071% of the shares, roughly 9.54 million GLYC shares worth $2.69 million.

ARTAL GROUP S.A. holds the second largest percentage of outstanding shares, with 13.3252% or 8.59 million shares worth $2.42 million as of 2024-06-30.